To further verify the findings, we performed qRT-PCR, and tested the expression levels of BDH1, HADHB and OXCT1 in several AML cell lines, i.e., THP1/t(9;11), U937/t(10;11), Kasumi-1/t(8;21), MV4;11/t(4;11), HL-60/del(16), K562/t(9;22) (CML) and normal HSCs. The gene discussed is BDH1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.